Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 6268Carcinoma, Renal Cell 1913Urinary Bladder Neoplasms 1670Kidney Neoplasms 930Breast Neoplasms 793Neoplasms 788Carcinoma, Transitional Cell 594Carcinoma, Non-Small-Cell Lung 524Neoplasm Metastasis 510Melanoma 485Ovarian Neoplasms 468Colorectal Neoplasms 454Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 290Stomach Neoplasms 274Sarcoma 267Uterine Cervical Neoplasms 264Non-Muscle Invasive Bladder Neoplasms 263Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 203Squamous Cell Carcinoma of Head and Neck 202Carcinoma, Hepatocellular 197Wilms Tumor 196Endometrial Neoplasms 189Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 146

Interventions

olaparib 1cabazitaxel 1Prednisone 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Prostate Cancer, Hereditary, 7 × Genitourinary × Clear all
NCT05384002 2026-06-04

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Fondazione del Piemonte per l'Oncologia

Completed
14,000 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT04052048 2026-04-02

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Immunis.AI

Recruiting
2,000 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7

NCT03263650 2026-02-17

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
96 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT06662708 2024-10-29

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase NA Not yet recruiting
200 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT01780701 2017-04-27

MRSI+RRP

OHSU Knight Cancer Institute

Completed
66 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡